Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12605376 | Methods of treating relapsing multiple sclerosis using an inhibitor of Bruton's tyrosine kinase | 🖼🧊📄§ | 2026-04-21 | 2041-04-01 | 0 | 31 |
| 12605392 | Cannabinoid composition and method of treating diabetic and chemotherapy induced neuropathic pain | 🖼🧊📄§ | 2026-04-21 | 2042-06-20 | 0 | 31 |
| 12605390 | Treatment of cancer and inhibition of metastasis | 🖼🧊📄§ | 2026-04-21 | 2041-10-27 | 0 | 31 |
| 12605417 | Compositions and methods for ameliorating symptoms associated with inflammatory skin disorders | 🖼🧊📄§ | 2026-04-21 | 2044-09-27 | 0 | 31 |
| 12605401 | Polymers, compositions and methods for treating hyperuricemia | 🖼🧊📄§ | 2026-04-21 | 2042-05-18 | 0 | 31 |
| 12605428 | Kinase NEK10 and its use in treating and diagnosing bronchiectasis and other respiratory disorders | 🖼🧊📄§ | 2026-04-21 | 2041-01-19 | 0 | 31 |
| 12605421 | Senescence inhibitor | 🖼🧊📄§ | 2026-04-21 | 2045-03-18 | 0 | 31 |
| 12605420 | Use of plant composition, traditional Chinese medicine composition in preparing medicine for treating COVID-19 | 🖼🧊📄§ | 2026-04-21 | 2042-10-19 | 0 | 31 |
| 12605419 | Flavonoid extract of Cyclocarya paliurus leaves and antibacterial drugs and/or antibacterial agents containing thereof | 🖼🧊📄§ | 2026-04-21 | 2040-08-20 | 0 | 31 |
| 12605425 | TNF muteins and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-26 | 0 | 31 |
| 12605423 | Peptide inhibitors targeting methyltransfer mechanism of SARS-CoV-2 | 🖼🧊📄§ | 2026-04-21 | 2041-09-08 | 0 | 31 |
| 12605424 | Treatment and prevention of pulmonary injury | 🖼🧊📄§ | 2026-04-21 | 2040-09-04 | 0 | 31 |
| 12605431 | Composition for treating or preventing myopathy, obesity or diabetes | 🖼🧊📄§ | 2026-04-21 | 2041-12-14 | 0 | 31 |
| 12605458 | Antibody-drug conjugate having acidic self-stabilization junction | 🖼🧊📄§ | 2026-04-21 | 2038-06-15 | 0 | 31 |
| 12605413 | Engineered probiotics for treatment and immunity against viruses | 🖼🧊📄§ | 2026-04-21 | 2041-04-19 | 0 | 31 |
| 12605416 | Compositions and methods for the treatment of skin diseases and conditions including eczema | 🖼🧊📄§ | 2026-04-21 | 2044-12-27 | 0 | 31 |
| 12606572 | Substituted heterocycles and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2045-10-07 | 0 | 31 |
| 12605363 | Oxymetazoline compositions | 🖼🧊📄§ | 2026-04-21 | 2042-12-23 | 0 | 31 |
| 12605364 | Methods of treating SARS-CoV-2 infections | 🖼🧊📄§ | 2026-04-21 | 2041-04-08 | 0 | 31 |
| 12606828 | Aptamers for use in the treatment of Coronaviridae infections | 🖼🧊📄§ | 2026-04-21 | 2041-04-09 | 0 | 31 |
| 12606848 | Globin gene therapy for treating hemoglobinopathies | 🖼🧊📄§ | 2026-04-21 | 2043-07-20 | 0 | 31 |
| 12606605 | Ultra-long acting insulin-Fc fusion proteins and methods of use | 🖼🧊📄§ | 2026-04-21 | 2043-01-10 | 0 | 31 |
| 12606630 | CD25 chimeric antigen receptors and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-08-28 | 0 | 31 |
| 12606529 | Sulfur and amide tropolone inhibitors of nucleotidyl transferases and uses therefor | 🖼🧊📄§ | 2026-04-21 | 2040-05-03 | 0 | 31 |
| 12605396 | Methods of treating mastitis with an orthosomycin antimicrobial compound | 🖼🧊📄§ | 2026-04-21 | 2041-12-23 | 0 | 31 |
| 12605368 | Suppression of neuroinflammation and composition and method therefor | 🖼🧊📄§ | 2026-04-21 | 2041-03-31 | 0 | 31 |
| 12605369 | Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses | 🖼🧊📄§ | 2026-04-21 | 2040-12-16 | 0 | 31 |
| 12605371 | Combination therapy for cancer | 🖼🧊📄§ | 2026-04-21 | 2041-07-26 | 0 | 31 |
| 12605372 | Combination therapy for the treatment of cancer | 🖼🧊📄§ | 2026-04-21 | 2042-11-09 | 0 | 31 |
| 12605382 | Pharmaceutical composition for preventing, alleviating, or treating cancer containing 2,6-dichloro-4-(4-(4-hydroxycyclohexylamino)-7H- pyrrolo[2,3-d]pyrimidin-5-yl)phenol as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2042-05-03 | 0 | 31 |
| 12605387 | Treatment of cancers using PI3 kinase isoform modulators | 🖼🧊📄§ | 2026-04-21 | 2040-07-24 | 0 | 31 |
| 12605434 | Composition for preventing or treating autoimmune diseases | 🖼🧊📄§ | 2026-04-21 | 2042-09-13 | 0 | 31 |
| 12599614 | Methods and pharmaceutical compositions for the treatment and prophylaxis of microbial infectious diseases and associated inflammatory disorders and for the treatment and prophylaxis of aging and associated diseases | 🖼🧊📄§ | 2026-04-14 | 2041-12-13 | 0 | 31 |
| 12599615 | Use of carotenoids in the treatment of senescence-related diseases | 🖼🧊📄§ | 2026-04-14 | 2040-03-04 | 0 | 31 |
| 12599554 | Pharmaceutical formulations comprising tadalafil | 🖼🧊📄§ | 2026-04-14 | 2041-07-28 | 0 | 31 |
| 12599588 | Inhibitor for V-ATPase activity, antibacterial agent, medicine, antibacterial method and screening method | 🖼🧊📄§ | 2026-04-14 | 2040-01-15 | 0 | 31 |
| 12599596 | Anti-tumor pharmaceutical composition based on immune checkpoint blockade and use thereof | 🖼🧊📄§ | 2026-04-14 | 2044-11-21 | 0 | 31 |
| 12599698 | Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12599648 | Pharmaceutical composition comprising a combination of a guanylate cyclase C (GUCY2C) agonist and a short-chain fatty acid or prodrug thereof | 🖼🧊📄§ | 2026-04-14 | 2040-06-30 | 0 | 31 |
| 12599654 | Immunogenic peptide fragments of metalloprotease ADAMTS-7 and uses thereof in anti-atherosclerosis and related diseases | 🖼🧊📄§ | 2026-04-14 | 2040-08-20 | 0 | 31 |
| 12599674 | Conjugates, their compositions, and their related methods | 🖼🧊📄§ | 2026-04-14 | 2045-06-24 | 0 | 31 |
| 12599659 | Attenuated avian reovirus strains 94826 C140 and 96139 C140 | 🖼🧊📄§ | 2026-04-14 | 2040-12-01 | 0 | 31 |
| 12599630 | Serum exosome with high osteogenesis and high angiogenesis, preparation method, and application thereof | 🖼🧊📄§ | 2026-04-14 | 2042-10-12 | 0 | 31 |
| 12599625 | Treatment of ARDS and other conditions caused by acutely elevated cytokine levels and post ARDS chronic cytokine production using inhaled anesthetics | 🖼🧊📄§ | 2026-04-14 | 2042-05-04 | 0 | 31 |
| 12599628 | Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions | 🖼🧊📄§ | 2026-04-14 | 2045-05-28 | 0 | 31 |
| 12599620 | Method for the treatment of chronic fatigue syndrome using an inhibitory or cytotoxic agent against plasma cells | 🖼🧊📄§ | 2026-04-14 | 2040-08-31 | 0 | 31 |
| 12600945 | Human Vγ9Vδ2T cell proliferation culture method and culture medium | 🖼🧊📄§ | 2026-04-14 | 2039-02-19 | 0 | 31 |
| 12600757 | Peptides inhibiting gamma-c-cytokine activity and methods of use | 🖼🧊📄§ | 2026-04-14 | 2038-04-04 | 0 | 31 |
| 12600702 | Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereof | 🖼🧊📄§ | 2026-04-14 | 2040-02-13 | 0 | 31 |
| 12600793 | Chimeric antigen receptors with MAGE-A4 specificity and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-07-24 | 0 | 31 |